Published Abstracts

1

Published Abstracts 1. Müller C., Zielinski C., Treiber G., Schernthaner G.: Natural killer cell activity and

antibody-dependent cellular cytotoxicity in recent-onset type 1 diabetes mellitus: A follow-up study under cyclosporin A treatment. Acta endocrinologica, Suppl. 274, Vol 111: 129 (1986)

2. Zielinski C. C., Müller C., Treiber G., Schernthaner G.: Natural killer cell activity and

antibody dependent cellular cytotoxyicity in recent-onset type 1 diabetes mellitus: A follow-up study under cyclosporin a therapy. European Journal of Clinical Investigation. 16: 2 (1986)

3. Aschauer H., Resch F., Aschauer-Treiber G., Müller Ch., Schönbeck G., Hatzinger R.,

Zielinski Ch.: Psychological functioning and natural immunity in depression. Abstract of the European Congress of immunology, Zagreb, Periodicum Biologorum. Volume 89, Suppl. 1: 54 (1987)

4. Resch F., Aschauer H., Aschauer-Treiber G., Schönbeck G., Hatzinger R., Zielinski

Ch., Müller Ch.: Cellular immunity in schizophrenia. Abstract of the 18 th International Congress of ISPNE, Durham, Neuroendocrinology Letters, Volume 9: 212 (1987)

5. Nutzinger D.O., de Zwaan M., Schönbeck G., Bugnar A., Macura R., Cayiroglu S.,

Berger P., Aschauer-Treiber G., Kiss A., Meryn S.: Controlled trial of Gluvoxamine and behaviour therapy in the treatment of depressed obese. Psychopharmacology, Volume 96: 349 (1988)

6. Aschauer-Treiber G., Aschauer H., Presslich O., Zielinski Ch.: Zelluläres Immunsystem

bei Opiatsucht : Einfluß von Entzugsbehandlungen. Abstract für 2. Drei-Länder-Symposium für Biologische Psychiatrie, Innsbruck, 1988. Fortschr. Neurol. und Psychiatr. 56 S1: 5 (1988)

7. Aschauer H., Aschauer-Treiber G., Isenberg K., Cloninger R.: Molekulargenetische

Untersuchungen bei schizophrenen Psychosen. Abstract für 2. Drei-Länder-Symposium für Biologische Psychiatrie, Innsbruck, 1988. Fortschr. Neurol. und Psychiatr. 56 S1: 27 (1988)

8. Aschauer H., Aschauer-Treiber G., Cloninger CR., Garver DL., Isenberg KE.:

Heterogeneity of schizophrenia: preliminary evidence for multiple genetic loci. Abstract for International Congress for multiple genetic loci. Abstract for International Congress on Schizophrenia Research. San Diego, April 1989. Schizophrenia Res. 2: 39 (1989)

9. Aschauer H.N., Aschauer-Treiber G., Isenberg K.E., Todd R.D., Garver D.L.,

Knesevich M., Cloninger C.R.: Molecularbiological Studies in Schizophrenia. Abstarct of 8 th World Congress of Psychiatry, Athens, Oct. 1989. In: Psychiatry Today, accomplishments and promises. Stefanis, CN., Soldatos CR. and Rabavilas AD (Eds.), Exerpta Medica, International congress series 899, Elesvier, Amsterdam: 45 (1989)

10. De Zwaan M., Schönbeck G., Nutzinger D., Caryioglu S., Macura R., Bugnar A., Berger

P., Aschauer-Treiber G., Kiss A., Meryn S.: Fluvoxamine and Behaviour Therapy in the Treatment of Depressed Obese. Pharmacopsychiatry, 22: 223 (1989)

Published Abstracts

2

11. Aschauer-Treiber G., Pesau B., Aschauer H., Pfersmann D., Presslich O., Resch F., Zielinski C.: Vergleich von zellulären Immunitätsparametern bei opiatabhängigen und methadonsubstituierten Patienten. Abstract: 44. Österreichischer Ärztekongreß. Wien, 22.- 27.10.1990, Österreichische Ärztezeitung 17 a: 63 (1990)

12. Aschauer-Treiber G., Berger P., Berger K., Aschauer H., Pfersmann D., Presslich O.,

Cloninger CR.: Personality Traits in patients with substance abuse. Abstract of the 5 th World Congress of Biological Psychiatry, Florence, June 1991. Biol. Psychiatry 29: 504 S (1991)

13. Meszaros K., Aschauer-Treiber G., Willinger U., Fessl D., Berger P., Berger K.,

Aschauer H.N.: Twin study in psychiatric patients: personality variants. Abstract of the 5 th World Congress of Biological Psychiatry, Florence, June 1991. Biol. Psychiatry 29 (11S): 549S (1991)

14. Rigal M., Meszaros K., Aschauer-Treiber G., Willinger U., Fessl D., Berger P., Berger

K., Petrau C., Matiasek C., Sindermann K., Aschauer H.N., Schönbeck G.: Fluvoxamine in the prevention of relapse in type 1 and 2 alcoholism. Abstract of the 5 th World Congress of Biological Psychiatry, Florence, June 1991. Biol. Psychiatry 29 (11S): 600S (1991)

15. Aschauer H.N., Aschauer-Treiber G., Meszaros K., Willinger U., Fessl D., Stompe T.,

Strobl R., Berger P., Berger K.: Personality in families with schizophrenia and bipolar illness. Abstract of the 5 th World Congress of Biological Psychiatry, Florence, June 1991. Biol. Psychiatry 29 (11S): 615S (1991)

16. Meszaros K., Willinger U., Aschauer-Treiber G., Fessl D., Stompe T., Aschauer H.:

The method of path analysis in genetic epidemiology of schizophrenia. Abstract for 2nd World Congress on Psychiatric Genetics. London, August 1991. Psychiatric Genetics 2 (1): 32-33 (1991)

17. Aschauer H.N., Aschauer-Treiber G., Meszaros K., Willinger U., Fessl D., Stompe T.,

Strobl R., Berger P., Berger K.: Personality in families with schizophrenia and bipolar illness. Abstract of the 5 th World Congress of Biological Psychiatry, Florence, June 1991. Biol. Psychiatry 29 (11S): 615S (1991).

18. Meszaros K., Willinger U., Aschauer-Treiber G., Fessl D., Stompe T., Aschauer H.:

The method of path analysis in genetic epidemiology of schizophrenia. Abstract for 2nd World Congress on Psychiatric Genetics. London, August 1991. Psychiatric Genetics 2 (1): 32-33 (1991)

19. Aschauer H.N., Meszaros K., Aschauer-Treiber G., Willinger U., Fessl D., Chaudry

H.R., Stompe T., Fuchs K., Sieghart W.: RFLP-linkage studies of schizophrenia on chromosome 2. Abstract for 2nd World Congress on Psychiatric Genetics Psychiatric Genetics. 2(1) : 12 (1991).

20. Fischer G., Presslich O., Schmid-Siegl B., Loimer N., Wenzl T., Fodor G.: Der Wandel

der Opiatentzugstherapie. Abstract of 3. Drei-Länder-Symposium für Biologische Psychiatrie, Lausanne 3.-5.9.1992. Fortschr. Neurol. Psychiat. 60 S1: 35 (1992).

21. Fischer G., Aschauer H.N., Pesau B., Presslich O., Resch F., Willinger U., Zielinski C.:

Zelluläre Immunitätsparameter bei opiatabhängigen Patienten. Abstract für 3. Drei-Länder-Symposium für Biologische Psychiatrie, Lausanne, Fortschr. Neurol.Psychiat. 60 S 1:35 (1992).

Published Abstracts

3

22. Aschauer H.N., Meszaros K., Fischer G., Willinger U., Lang M., Beran H., Resinger E.,

Lenzinger E., Strobl R., Stompe T., Fuchs K., Sieghart W., Isenberg K.E., Todd R.D., Reich T., Cloninger C.R.: Kopplungsstudien in Familien schizophrener Probanden am Chromosom 2. Abstract für 3. Drei-Länder-Symposium für Biologische Psychiatrie, Lausanne, 3.-5.9.1992 Fortschr. Neurol. Psychiat. 60 S1: 26 (1992).

23. Aschauer H.N., Meszaros K., Willinger U., Fischer G., Beran H., Lang M., Stompe T.,

Strobl R., Fuchs K., Sieghart W., Berger K., Berger P. Isenberg K.E., Todd R. D., Reich T., Cloninger C.R.: Schizophrenia Family Study: moleculargenetics, personaltities. Abstract of XVIII th CINP Congress, Nice, France, June 28-July 2, 1992. Clin Neuropharm. 15, Suppl. 1, Pt. B.: 42 (1992).

24. Aschauer HN., Meszaros K., Aschauer-Treiber G., Isenberg K., Willinger U., Fuchs K.,

Sieghart W., Beran H., Lang M., Strobl R., Todd RD., Reich T., Cloninger CR.: RFLP linkage study in schizophrenia on chromosome 2. Abstract of the 6th study in schizophrenia, Bad Gastein, January 1992. Schizophrenia Res. 6 (2): 89 (1992)

25. Meszaros K., Aschauer H.N., Willinger U., Isenberg K.E., Todd R.D., Fischer G., Beran

H., Lenzinger E., Resinger E., Strobl R., Fuchs K., Sieghart W., Reich T., Cloninger C.R.: Schizophrenia Linkage Studies on Chromosome 2q. Abstract: 4th International Congress on Schizophrenia Research. Colorado Springs, 17.-21 April, 1993. Schizophr. Res. 9: 121 (1993).

26. Willinger U., Meszaros K., Aschauer HN., Fischer G., Beran H., Lenzinger E., Resinger

E., Strobl R.: Exogenous variables describing familial schizophrenia. Abstract: 4th International Congress on Schizophrenia Research. Colorado Springs, 17.-21 April, 1993. Schizophr. Res. 9: 128 (1993).

27. Willinger U., Aschauer HN., Meszaros K., Fessl D., Beran H., Fischer G., Schönbeck

G., Rigal M., Matiasek C., Petrau C., Sindermann K.: European Fluvoxamine in Alcoholism study group: Type I and Typ II alcoholism subtypes and the TPQ. Abstract : 1993 World Congress on Psychiatric Genetics, New Orleans, 2-5 October 1993. Psychiatric Genetics 3 (3): 171 (1993)

28. Meszaros K., Aschauer HN., Willinger U., Beran H., Lenzinger E., Reiter E., Heiden AM.,

Fischer G., Strobl R.: Schizophrenia-sibships: studies of sex concordance. Abstract: 1993 World Congress on Psychiatric Genetics, New Orleans, 2-5 October 1993. Psychiatric Genetics 3 (3): 178 (1993)

29. Meszaros K., Willinger U., Lang M., Beran H., Fischer G., Lenzinger E., Reiter E.,

Resinger E., Strobl R., Aschauer HN.: Mediating variables in familial schizopprenia. Proceedings of the IX World Congress of Psychiatry, Rio de Janeiro, World Psychiatric Association (1993)

30. Meszaros K., Heiden AM., Willinger U., Lenzinger E., Reiter E., Beran H., Stompe T.,

Resinger E., Fischer G., Berger P., Berger K., Aschauer HN.: The ʻTridimensional Personality Questionnaireʼ: A German version in schizophrenics and normal probands. Abstract: Seventh Biennal Winter Workshop on Schizophrenia, Diablerets, Switzerland, 23-28 January 1994. Schizophrenia Research 11 : 183 (1994)

Published Abstracts

4

31. Fischer G., Schneider C., Diamant K., Presslich O., Breza S., Kasper S.: Erfahrungen in der Krisenintervention substanzabhängiger Patienten. Abstract für 32.Jahrestagung der Österreichischen Gesellschaft für Kinder-und Jugendheilkunde, Pädiatrie und Pädiologie (1994)

32. Fischer G., Diamant K., Schneider C., Presslich O., Podreka I., Kasper S.:

Singlephoton- Emissionstomographie (SPECT)- Untersuchung bei opiatabhängigen Patienten. Abstract für Biologische Psychiatrie, München, Fortschr. Neurol. Psychiatr. 62 (S2): 125 (1994).

33. Wagner E., Fischer G., Presslich O., Frey R., Diamant K., Wenzel T., Schneider C.,

Kasper S.: Der Einsatz von Morphinpentahydrat in der Detoxifikationsbehandlung Opiatabhängiger. Abstract für Biologische Psychiatrie, München, Fortschr. Neurol. Psychiatr. 62 (S2): 126 (1994).

34. Fischer G., Schneider C., Diamant K., Pezawas L., Lenzinger E., Podreka I., Brücke T.,

Thurnherr M., Kasper S.: Pathological regional cerebral blood flow in opiate dependent patients. Abstract für: Wissenschaftliche Sommertage der Gesellschaft der Ärzte. In Druck: Wiener Klinische Wochenschrift

35. Diamant K., Fischer G., Aschauer HN., Schneider C., Pfersmann D., Lenzinger E.,

Zielinski C., Kasper S.: Lytic immune cellular function in opioid dependent patients. Abstract für: Wissenschaftliche Sommertage der Gesellschaft der Ärzte. In Druck: Wiener Klinische Wochenschrift

36. Andel R., Fischer G., Schneider C., Forster G., Schindler S., Pezawas L., Diamant K.,

Niedermayer I., Kasper S.: Pregnancy and opiate dependence. Abstractbook: ICAA 1996 Amsterdam - International Institute on the Prevention and Treatment of Dependen-cies p. 4 (1996)

37. Diamant K., Fischer G., Pezawas L., Schindler S., Schneider C., Forster G., Eder H., Kasper S.: Opiate-withdrawal treatment with buprenorphine. Abstractbook: 58th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), San Juan, p. 34 (1996)

38. Diamant K., Fischer G., Schneider C., Lenzinger E., Pezawas L., Kasper S.: Buprenorphin in der ambulanten Entzugsbehandlung opiatabhängiger Patienten. Abstractbook: 11. Wissenschaftliche Tagung der Deutschen Gesellschaft für Suchtforschung und Suchttherapie, Lübeck, Deutschland, 27.-30.03.1996

39. Diamant K., Fischer G., Schneider C., Lenzinger E., Wagner E., Pezawas L., Kasper S.: Langzeitsubstitution mit Morphium. Abstractbook: 11. Wissenschaftliche Tagung der Deutschen Gesellschaft für Suchtforschung und Suchttherapie, Lübeck, Deutschland, 27.-30.03.1996

40. Diamant K., Fischer G., Schneider C., Pezawas L., Schindler S., Forster G., Kasper S.: Ambulante Opiatentzugstherapie mit Buprenorphin. Neuropsychiatrie 1: 21 (1996)

41. Diamant K., Fischer G., Schneider C., Pezawas L., Schindler S., Kasper S.: Ambulante Opiatentzugsbehandlung mit Buprenorphin. Fortschritte der Neurologie Psychiatrie 64 (2): 133 (1996)

Published Abstracts

5

42. Fischer G., Aschauer HN., Willinger U., Diamant K., Schneider C., Kasper S.: Zelluläre Parameter erhöhen sich unter Methadon-Substitution. Abstract: 11. Wissenschaftliche Tagung der Deutschen Gesellschaft für Suchtforschung und Suchttherapie., Lübeck., Deutschland., 27.-30.03.1996

43. Fischer G., Diamant K., Frey R., Presslich O., Eder H., Kasper S.: Opiatentzugsbe-handlung mit Gammahydroxybuttersäure. Fortschritte der Neurologie Psychiatrie 64(2): 134 (1996)

44. Fischer G., Diamant K., Pezawas L., Schindler SD., Podreka I., Kasper S.: Abnormal regional cerebral blood flow in opoid dependent patients. European Neuropsychopharmacology 6 (Suppl 4): S4-129 (1996)

45. Fischer G., Diamant K., Schneider C., Frey R., Heiden A., Pezawas L., Presslich O., Kasper S.: Opiatentzugsbehandlung mit Gammahydroxybuttersäure. Neuropsychiatrie 1: 21 (1996)

46. Fischer G., Diamant K., Schneider C., Pezawas L., Schindler S., Forster G., Eder H., Kasper S.: Oral morphine maintenance program. Abstractbook: 58th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), San Juan, p. 40 (1996)

47. Fischer G., Schneider C., Diamant K., Frey R., Heiden A., Kasper S.: Gamma hy-droxybutyric acid for detoxification treatment of opiate-dependent patients. Abstractbook: 149th Annual Meeting of the American Psychiatric Association, New York, p. 141 (1996)

48. Fischer G., Schneider C., Diamant K., Pezawas L., Schindler S., Kasper S.: Opiate-withdrawal treatment with buprenorphine. Abstractbook: 149th Annual Meeting of the American Psychiatric Association, New York, 04.-09.05.1996

49. Fischer G., Diamant K., Pezawas L., Schindler SD., Podreka I., Kasper S.: Abnormal regional cerebral blood flow in opoid dependent patients. European Neuropsychopharmacology 6 (Suppl 4): S4-129 (1996)

50. Fischer G., Diamant K., Schneider C., Frey R., Heiden A., Pezawas L., Presslich O., Kasper S.: Opiatentzugsbehandlung mit Gammahydroxybuttersäure. Neuropsychiatrie 10 (1): 21 (1996)

51. Grünberger J., Linzmayer L., Fischer G., Pezawas L.: Eine neue Methode zur Messung der zentralnervösen Aktivierung: Fourieranalyse der Messung der Pupillenoszillationen bei Drogenabhängigen. Neuropsychiatrie 10: 20 (1996)

52. Forster G., Fischer G., Diamant K., Schneider C., Pezawas L., Kasper S.: Oral mor-phine maintenance program. Abstractbook: 149th Annual Meeting of the American Psychiatric Association, New York, p. 138 (1996)

53. Forster G., Fischer G., Pezawas L., Schindler S., Eder H., Schneider C., Kasper S.: Drogentherapie und Schwangerschaft. Fortschritte der Neurologie Psychiatrie 64(2): 88 (1996)

54. Forster G., Fischer G., Schneider C., Diamant K., Pezawas L., Schindler S., Kasper S.: Alternative Substitutionstherapien. Neuropsychiatrie 1: 21-22 (1996)

Published Abstracts

6

55. Forster G., Fischer G., Schneider C., Diamant K., Schindler S., Pezawas L., Kasper S.: Pregnancy and opiate dependence. Abstractbook: 58th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), San Juan, p. 41 (1996)

56. Niedermayer I., Fischer G., Pezawas L., Schindler S., Forster G., Diamant K., Schneider C., Andel R., Kasper S.: Adolescent drug addicts in a drug-addiction out-patient clinic in Vienna. Abstractbook: ICAA 1996 Amsterdam - International Institute on the Prevention and Treatment of Dependencies, p. 51 (1996)

57. Pezawas L., Fischer G., Diamant K., Schneider C., Forster G., Schindler S., Eder H., Thurnher M., Kasper S.: Computertomographisch faßbare Veränderungen bei opiatab-hängigen Patienten. Fortschritte der Neurologie Psychiatrie 64 (2): 132 (1996)

58. Pezawas L., Fischer G., Diamant K., Schneider C., Podreka I., Brücke T., Thurnherr M., Kasper S.: Abnorme Hirnperfusion bei Opiatabhängigkeit: SPECT-Untersuchungen mit TC99m-HMPAO. Neuropsychiatrie 1: 20 (1996)

59. Pezawas L., Fischer G., Diamant K., Schneider C., Podreka I., Brücke T., Kasper S.: Buprenorphin in der ambulanten Entzugsbehandlung opiatabhängiger Patienten. Abstractbook: 11. Wissenschaftliche Tagung der Deutschen Gesellschaft für Suchtforschung und Suchttherapie, Lübeck, Deutschland, 27.-30.03.1996

60. Pezawas L., Fischer G., Diamant K., Schneider C., Schindler S., Forster G., Eder H., Podreka I., Kasper S.: Changes in brain perfusion during opioid dependence: SPECT imaging with TC-99M-HMPAO. Abstractbook: 58th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), San Juan, p. 108 (1996)

61. Pezawas L., Fischer G., Diamant K., Schneider C., Schindler S., Kasper S.: Abnormal brain perfusion during opioid dependence: SPECT imaging with TC-99M-HMPAO. Abstractbook: 149th Annual Meeting of the American Psychiatric Association, New York, p. 198-199 (1996)

62. Schindler S., Fischer G., Diamant K., Eder H., Schneider C., Pezawas L., Forster G., Kasper S.: Gammahydroxybutyric acid for detoxification. Abstractbook: 58th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), San Juan, p. 122 (1996)

63. Schindler S., Pezawas L., Fischer G., Diamant K., Schneider C., Forster G., Eder H., Podreka I, Kasper S.: Changes in brain perfusion during opioid dependence: SPECT imaging with Tc-99m-HMPAO. European Psychiatry 11 (Suppl 4): 329 s (1996)

64. Schneider C., Fischer G., Diamant D., Pezawas L., Forster G., Eder H., Kasper S.: Drogenabhängigkeit und Schwangerschaft. Neuropsychiatrie 1: 19 (1996)

65. Schneider C., Fischer G., Diamant K., Forster G., Pezawas L., Kasper S.: Pregnancy and opiate dependence. Abstractbook: 149th Annual Meeting of the American Psychiatric Association, New York, p. 139 (1996)

66. Diamant K., Fischer G., Etzersdorfer P., Eder H., Jagsch R., Schmidl-Mohl K., Gombas W., Schindler S.: Comparision of morphine and methadone maintenance in pregnant opiate addicts, Verein zur Förderung von Wissenschaft und Forschung in den neuen Universitätskliniken im AKH, Posterpräsentation, Wien 03.10.1997

Published Abstracts

7

67. Eder H., Fischer G., Jagsch R., Schindler S., Gombas W., Pezawas L.: Comparison of morphine and methadone in opiate addicts. College on Problems of Drug Dependence (CPDD), Nashville, USA (1997)

68. Eder H., Fischer G., Jagsch R., Schindler S., Gombas W., Pezawas L.: Comparision of

Buprenorphine and Methadone in opiate addicts, 3rd European Conference on Rehabilitation and Drug policy, Oslo 01. - 05.06.1997

69. Eder H., Fischer G., Jagsch R., Schindler S., Gombas W, Pezawas L.: Comparison of

buprenorphine and methadone in opiate addicts. Heroin addiction in Europe, Ljubljana, Slovenija, 17.-20.09.1997

70. Eder H., Fischer G., Schmidl-Mohl K., Etzersdorfer P., Jagsch R., Gombas W., Kasper

S.: Buprenorphine Maintenance in Pregnant Opiate Addicts. Pharmacopsychiatry, 30:163 (1997)

71. Eder H., Fischer G., Schmidl-Mohl K., Etzersdorfer P., Jagsch R., Gombas W., Kasper

S.: Buprenorphine Maintenance in pregnant opiate addicts, Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmapsychiatrie, Nürnberg, 8. - 11.10.1997

72. Etzersdorfer P., Schmidl-Mohl K., Herbacek A., Diamant K., Fischer G.: Pregnant opiate

addicts undergoing opioid maintenance in a comprehensive treatment model, First International Congress: Women in the health care system, 06. - 08.03.1997

73. Etzersdorfer P., Fischer G., Eder H., Jagsch R., Schmidl-Mohl K., Gombas W.,

Schindler S.: Comparision of Morphine and Methadone Maintenance in pregnant opiate addicts, American Psychiatric Association Annual Meeting; San Diego 17. - 22.05.1997

74. Etzersdorfer P.,Fischer G.: Comparision of Morphine and Methadone Maintenance in

Pregnant Opiate Addicts, International Council on Alcohol and Addictions, Cairo 17. - 22.05.1997

75. Etzersdorfer P., Fischer G., Eder H., Jagsch R., Schmidl-Mohl K., Gombas W.,

Schindler S.: Morphine and Metadone Maintenance in pregnant addicts, Heroin Adiction in Europe Congress Ljubljana, 17. - 20.09.1997

76. Etzersdorfer P., Fischer G., Schmidl-Mohl K., Eder H., Jagsch R., Gombas W., Kasper

S.: Buprenorphine maintenance in pregnant opiate addicts, Verein zur Förderung von Wissenschaft und Forschung in den neuen Universitätskliniken im AKH, Posterpräsentation Wien, 03.10.1997

77. Fischer G., Eder H., Gombas W., Okamoto I., Schmidl-Mohl K., Schindler S.:

Prevalence of hepatitis C in a consecutive investigation of opiate dependent subjects in a drug addiction clinic. International Institute on the Prevention and Treatment of Dependencies (ICAA), Cairo, Egypt (1997)

78. Fischer G., Schmidl-Mohl K., Etzersdorfer P., Eder H., Jagsch R., Gombas W.:

Buprenorphine Maintenance in Pregnant Opiate, American Psychiatric Association Annual Meeting, San Diego 17. 22.05.1997

79. Fischer G.: Prevalence of Hepatitis C in a Consecutive Investigation of Opiate

Dependent Subjects in a Drug Addiction Clinic, International Council on Alcohol and Addictions, Cairo, 17. - 22.05.1997

Published Abstracts

8

80. Fischer G., Eder H., Gombas W., Okamoto I., Schmidl-Mohl K., Schindler S.: Prevalence of Hepatitis in a consecutive investigation of opiate dependent subjects in a drug addiction clinic, Europe Against Drug Abuse, 3rd European Conference on Rehabilitation and Drug policy, Oslo 01. - 05.06.1997

81. Fischer G., Eder H., Jagsch R., Diamant K., Gombas W., Kasper S.: Relapse

Prevention with opioid Agonists and Antagonists in Heroin Addiction, European College of Neuropsychopharmacology Congress, Vienna, 13. - 17. 09.1997

82. Fischer G., Gombas W., Eder H., Jagsch R., Schindler S., Pezawas L.: Comparision of

Buprenorphine and Methadone in Opiate Addicts, European College of Neuropsychopharmacology Congress, Vienna, 13. - 17.09.1997

83. Fischer G.: Diversifizierte Substitutionstherapie bei Opiatabhängigkeit, Van Swieten

Kongress 1997, 23.10.1997 84. Fischer G., Etzersdorfer P., Diamant K., Eder H.: Oral substitution treatment for opiate-

dependent pregnant women using methadone, morphine and buprenorphine, 1997 Syllabus and proceedings summary, Washington 24. - 28.10.1997

85. Fischer G., Eder H., Jagsch R., Diamant K., Gombas W., Kasper S.: Relapse

Prevention with Opioid Agonists and Antagonists in Heroin Addiction. Eur Neuropsychopharmacol, 7(2):99 (1997)

86. Fischer G., Gombas W., Eder H., Jagsch R., Schindler S., Pezawas L., Kasper S.:

Comparision of buprenorphine and methadone in opiate addicts. Eur Neuropsychopharmacol, 7(2):262 (1997)

87. Gombas W., Fischer G., Eder H., Jagsch R., Schindler S., Pezawas L., Kasper S.:

Comparision of Buprenorphine and Methadone in Opiate Addicts. Pharmacopsychiatry, 30:171 (1997)

88. Gombas W., Fischer G., Eder H., Jagsch R., Schindler S., Pezawas L., Kasper S.:

Comparision of Buprenorphine and Methadone in opiate addicts, Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmapsychiatrie, Nürnberg 8. - 11. Oktober 1997

89. Gombas W., Fischer G., Eder H., Jagsch R., Schmidl-Mohl K.: Pregnant opiate addicts

undergoing methadone or morphine maintenance. Europe against drug abuse (EADA), Oslo, Norway, 01-05.06.1997

90. Gombas W., Fischer G., Eder H., Okamoto I., Schmidl-Mohl K., Schindler S.:

Prevalence of hepatitis C in a consecutive investigation of opiate dependent subjects in a drug addiction clinic. Heroin addiction in Europe, Ljubljana, Slovenija, 13.-17.09.1997

91. Gombas W., Fischer G., Eder H., Okamoto I., Schmidl-Mohl K., Schindler S.:

Prevalence of Hepatitis C in a consecutive investigation of opiate dependent subjects in a drug addiction clinic, Verein zur Förderung von Wissenschaft und Forschung in den neuen Universitätskliniken im AKH Wien, Posterpräsentation 03.10.1997

92. Meszaros K., Fischer G., Willinger U., Todd RD., Beran H., Strobl R., Lang M., Fuchs

K., Sieghart W., Reich T., Cloninger CR., Aschauer H.: No proof of linkage between schizophrenia-related disorders including schizophrenia and chromosome 2q21 region, American Journal of Medical Genetics, Neuropsychiatric Genetics 74: 6 (1997)

Published Abstracts

9

93. Schmidl-Mohl K.: Buprenorphine Maintenance in pregnant opiate addicts, 41st international Institute on the Prevention and treatment of dependencies, International Council on Alcohol and Addictions, Cairo 17. - 22.05.1997

94. Schmidl-Mohl K., Fischer G., Etzersdorfer P., Eder H., Jagsch R.: Buprenorphine

maintenance in pregnant opiate addicts. Eur Neuropsychopharmacol,7(2):263 (1997) 95. Eder H, Fischer G., Gombas W, Jagsch R, Habeler A, Nagy C, Lennkh C

Erhaltungstherapie mit synthetischen Opioiden zur Behandlung der Opiatabhängigkeit. 25. Wissenschaftliche Tagung der Österreichischen Gesellschaft für Neurologie und Psychatrie, Gmunden 22.- 25.04.1998 Neuropsychatrie 12/1, 37 (1998)

96. Elstner, Fiala- Preinsperger, Muzik M, Schuch, Fischer G., Langer M, Weninger M,

Berger E: Entwicklung von Kindern substanzabhängiger Mütter. 25. Wissenschaftliche Tagung der Österreichischen Gesellschaft für Neurologie und Psychatrie, Gmunden 22.- 25.04.1998 Neuropsychatrie 12/1, 37 (1998)

97. Fischer G., Eder H, Gombas W, Habeler A, Nagy C, Lennkh C: Drogenabhängigkeit

und Schwangerschaft. 25. Wissenschaftliche Tagung der Österreichischen Gesellschaft für Neurologie und Psychatrie, Gmunden 22.- 25. April. Neuropsychatrie 12/1, 38 (1998)

98. Fischer G., Eder H, Gombas W, Habeler A, Nagy C, Lennkh C: Prävalenz von Hepatitis

C und HIV bei opiatabhängigen PatientInnen in einer ambulanten Drogentherapieeinrichtung. 25. Wissenschaftliche Tagung der Österreichischen Gesellschaft für Neurologie und Psychatrie, Gmunden 22.- 25. April. Neuropsychatrie 12/1, 40 (1998)

99. Eder H, Fischer G., Gombas W, Jagsch R, Nagy C, Lennkh C, Kasper S:

Buprenorphine and methadone: A comparison trial. New Research, American Psychiatric Association (APA). 1998 Annual Meeting, Toronto, Book of Abstracts NR 50, 81 (1998)

100. Fischer G., Jagsch R, Nagy C, Lennkh C,Eder H, Gombas W, Langer M: Pregnancy

and buprenorphine maintenance. New Research, American Psychiatric Association (APA). 1998 Annual Meeting , Toronto, Book of Abstracts NR 315, 152 (1998)

101. Jagsch R, Windhaber J, Gombas W, Eder H, Fischer G: Quality of life in opiate

abusers. The 12 th conference of the european health psychology society, Book of Abstracts p.86 (1998)

102. Pezawas L, Fischer G., Diamant K, Plöchl W, Eder H, Thurnher M, Kasper S:

Morphological changes in opioid dependence. National institute on drug abuse- NIDA. The College on Problems of Drug Dependence- CPDD: Proceedings of the 59th annual scientific meeting p.155. (1998)

103. Fischer G., Schmidl-Mohl K, Etzersdorfer P, Eder H, Jagsch R, Gombas W:

Buprenorphine maintenance in pregnant opiate addicts. National Institute on Drug Abuse (NIDA). The College on Problems of Drug Dependence (CPDD): Proceedings of the 59th annual scientific meeting p.134. (1998)

104. Etzersdorfer P, Fischer G., Eder H, Jagsch R, Schmidl-Mohl K, Gombas W:

Comparison of morphine and methadone maintenance in pregnant opiate addicts. National Institute on Drug Abuse (NIDA). College on Problems of Drug Dependence (CPDD): Proceedings of the 59th annual scientific meeting p.343. (1998)

Published Abstracts

10

105. Fischer G., Jagsch R, Nagy C, Lennkh C, Eder H, Gombas W, Langer M: Pregnancy

and buprenorphine maintenance. National Institute on Drug Abuse (NIDA). College on Problems of Drug Dependence (CPDD): Proceedings of the 60th annual scientific meeting p. 41. (1998)

106. Eder H, Fischer G., Gombas W, Jagsch R, Haberler B, Rössler B, Kasper S:

Methadone and buprenorphine in maintenance therapy for opioid dependence. Eur Neuropsychopharmacol, 8 (2): 286-287 (1998)

107. Fischer G., Eder H, Jagsch R, Rössler B, Langer M: Safety study of buprenorphine

during pregnancy. Eur Neuropsychopharmacol, 8 (2): 287 (1998) 108. Pezawas L, Fischer G., Diamant K, Schneider C, Schindler S, Thurnher M, Ploechl W,

Eder H, Kasper S.: Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurments. Biol Psychiatry 45: 113S (1999)

109. Fischer G., Aschauer HN, Kasper S, Eder H, Gombas W, Jagsch R.: Methadone and

Buprenorphine in pregnant Opioid-Dependance. Current Opinion in Psychiatry, 12 (1): 47 (1999)

110. Aschauer HN, Meszaros K, Lenzinger E, Hornik K, Füreder T, Willinger U, Fischer G,

Schönbeck G.: Novelty seeking predicts relapse in detoxified male alcohol dependents. Eur Neuropsychopharmacology, 9 (5): 336 (1999)

111. Fischer G., Eder H, Jagsch R, Peternell A,Weninger M, Langer M, Aschauer HN.:

Open-label maintenance study with buprenorphine in pregnant opiod addicts. Eur Neuropsychopharmacology 9 (5): 340 (1999)

112. Eder H, Fischer G., Gombas W, Jagsch R, Peternell A, Stühlinger G, Aschauer HN,

Kasper S.: Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Eur Neuropsychopharmacology, 9 (5) 339 (1999)

113. Lenzinger E, Meszaros K, Willinger U, Fischer G., Schönbeck G, Hornik K, Aschauer

HN.: Prevalence and relapse predicting value of Cloningerʼs alcoholism types. Eur Neuropsychopharmacology 9 (5) 344 (1999)

114. Eder H., Kraigher D., Peternell A., Ortner R., Schindler SD., Kasper S., Fischer G.:

Methadone versus slow release morphine for the treatment of opioid dependence. Drug and Alcohol Dependence, 63: S42 (2001)

115. Fischer G., Eder H., Peternell A., Kraigher D.: Psychophysiological parameters of

buprenorphine and methadone maintained opioid-dependent patients. Drug and Alcohol Dependence, 63: S47 (2001)

116. Fischer G.: Management of neonatal abstinence syndrome in newborns of opioid

maintained women. 12 th International Conference on the Reduction of Drug Related Harm, New Dehli, Poster 2.-5.4.2001

117. Eder H., Fischer G., Peternell A., Topitz A., Habeler A. Kraigher D.: Maintenance

therapy with synthetic opioids within a multidisciplinary program. 12 th International Conference on the Reduction of Drug Related Harm, New Dehli, Poster, 2.-5.4.2001

Published Abstracts

11

118. Eder H., Peternell A., Kraigher D., Ortner R., Stühlinger G., Fischer G.: Slow release morphine versus methadone maintenance for the treatment of opioid dependence. ASAM, Los Angeles CA, 19.-22.4.2001

119. Eder H., Peternell A., Kraigher D., Ortner R., Stühlinger G., Fischer G.: Maintenance

therapy of opioid dependence with slow release morphine and methadone. 7th World Congress of Biological Psychiatry (WCBP), Berlin, 1.-6.7.2001

120. Fischer G., Kraigher D., Ortner R., Schindler SD.: Opiatabhängige Schwangere und ihre

Kinder. Poster: Mehr als Abhängig. AID Berlin & Ärztekammer Berlin, 18.5.2001 121. Fischer G., Kraigher D., Ortner R., Schindler SD.: Standards in the treatment of

substance dependent pregnant women. Poster: Risk Addiction/Addiction Risk API, Wien, 7.-10.5.2001

122. Schindler S., Eder H., Peternell A., Ortner R., Kraigher D., Opgenoorth., Fischer G.:

Maintenance therapy with synthetic opioids and driving aptitude. European Neuropsychopharmacology, 11:S3, 336 (2001)

123. Ortner R., Peternell A., Kraigher D., Schindler S.-D., Topitz A., Fischer G.: Additional

consumption of cocaine during methadone maintenance therapy. European Neuropsychopharmacology , 11:S3, 336 (2001)

124. Schindler S., Eder H., Peternell A., Ortner R., Kraigher D., Opgenoorth., Fischer G.:

Maintenance therapy with synthetic opioids and driving aptitude. European Neuropsychopharmacology, 11: 3, 336 (2001)

125. Ortner R., Peternell A., Kraigher D., Schindler S.-D., Topitz A., Fischer G.: Additional

consumption of cocaine during methadone maintenance therapy. European Neuropsychopharmacology , 11: 3, 336 (2001)

126. Eder H., Kraigher D., Peternell A., Ortner R., Schindler SD., Kasper S., Fischer G.:

Methadone versus slow release morphine for the treatment of opioid dependence. Drug and Alcohol Dependence, 63: 42 (2001)

127. Fischer G., Eder H., Peternell A., Kraigher D.: Psychophysiological parameters of

buprenorphine and methadone maintained opioid-dependent patients. Drug and Alcohol Dependence, 63: 47 (2001)

128. Fischer G., Ortner R., Schindler S., Jagsch R.: Office-based prescription study with

buprenorphine. Drug and Alcohol Dependence 66:57 (2002) 129. Eder H., Kraigher D., Peternell A., Schindler S., Jagsch R., Kasper S., Fischer G.:

Delayed release morphine and methadone for maintenance therapy in opioid dependence. Drug and Alcohol Dependence, 66:180 (2002)

130. Fischer G.: Substance dependence and pregnancy – diversification in treatment is

improving the outcome. Etiology and Treatment of Addiction – A Biomedical Approach, Abstract Book, ISAM (2003)

131. Primorac A, Fischer G:. Frauen sind anders und schwerer krank als Männer. 3.

Jahrestagung der Österreichischen Gesellschaft für Psychiatrie und Psychotherapie. 2.-4. Oktober 2003, Bad Ischl

Published Abstracts

12

132. Ebner N., Primorac A., Fischer G.: Suchterkrankung – Unterschiede zwischen Frauen und Männern. Suchtmedizin in Forschung und Praxis 6 (2):126 (2004)

133. Fischer G.: Substitutionsbehandlung in der Schwangerschaft. HIV und

Schwangerschaft – 4. Interdisziplinäres Arbeitstreffen in Eltville: 26-28 (2004) 134. Primorac A, Ortner R, Jagsch R., Rohrmeister K, Langer M & Fischer G: Double-

dummy, double-blind comparison of buprenorphine and methadone in pregnant opioid dependent women. CPDD – The College on Problems of Drug Dependence, 66th Annual Scientific Meeting of the College of Problems of Drug Dependence, Puerto Rico, June 12th-17th , 2004

135. Fischer G, Primorac A, Ebner N: Aktuelle Aspekte in der Diagnostik und Behandlung

von Störungen durch Opioide. DGPPN 2004 Abstractband. Der Nervenarzt 75, Suppl. 2: 178 (2004)

136. Ebner N, Primorac A, Fischer G. Suchterkrankung – Unterschiede zwischen Frauen

und Männern. 5. Interdisziplinärer Kongress für Suchtmedizin, Suchtmedizin in Forschung und Praxis, München 2004, 1.-3.Juli

137. Baewert A, Ebner N, Thau K, Fischer G. Treatment of hepatitis C/subtype 2 or 3 with

pegylated interferon in combination with ribavirin in a poplation of opioid dependent patients. CPDD – The College on Problems of Drug Dependence, 67th Annual Scientific Meeting, Orlando, June18-25, 2005

138. Ebner N, Winklbaur B, Baewert A, Thau K, Fischer G. Opioid-Dependent Patients in

Maintenance Therapy and Treatment of Hepatitis C. NIDA International Forum. International Trends and Needs in Drug Abuse Reserach. Abstracts, p.9, 2006

139. Winklbaur B., Ebner N., Nagy C., Thau K., Fischer G. The influence of cigarette

smoking in opioid-maintained pregnant women. CPDD 2006, Mini-Program: Focus on Women & Sex/Gender Differences: p 81, 2006

140. Fischer G, Ebner N, Winklbaur B, Thau K.: Gender in relation to treatment in

psychopharmacology. European Neuropsychopharmacology 16 (Suppl.): 206-207, 2006 141. Ebner N, Aeschbach Jachmann C, Winklbaur B, Baewert A, Thau K &. Fischer G.

Outcome of hepatitis C treatment in opioid-dependent, maintained patients. CPDD Quebec, Canada, July 20th, 2007

142. Winklbaur B, Ebner N, Baewert A, Jagsch R & Fischer G: Management des neonatalen

Abstinenzsyndroms (NAS) bei Kindern von opioid-abhängign Müttern in Erhaltungstherapie. Suchtmed 8(2) 85; 2006

143. Winklbaur B, Ebner N, Jagsch R, Baewert A, Thau K, Fischer G. Impact of Cigarette

Smoking in Opioid-Maintained Pregnant Women – Neonatal Consequences (abstract). ICRDRH International Conference on the Reduction of Drug Related Harm Conference, Warsaw, May 13-17, 2007

144. Ebner N, Aeschbach-Jachmann C, Winklbaur B, Baewert A, Thau K, Fischer G CPDD

(The College on Problems of Drug Dependence), 67th Annual Scientific Meeting, Quebec, June 20, 2007

Published Abstracts

13

145. Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A, Thau K, Fischer G: Opioid maintenance therapy in pregnant women – consequences? WFSBP World Federation of Societies of Biological Psychiatry Congress - Session Addictive Disorders 18:45-19:45, Santiago, Chile, April 19, 2007

146. Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A, Thau K,

Fischer G. Auswirkungen von Therapie mit Opioiden während der Schwangerschaft. 8. Interdisziplinärer Kongress für Suchtmedizin, Munich, June 2007

147. Winklbaur B, Ebner N, Sachs G, Thau K, Fischer G. Schizophrenia and Substance

abuse & dependence European Assoction of Addiction Therapy- EAAT-September 11th, 2007

148. Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A, Thau K,

Fischer G. Neonatal Abstinence Syndrome in Neonates of Opioid Maintained Women. (abstract) EAAT September 14, 2007

149. Winklbaur B, Ebner N, Jagsch R, Thau K & Fischer G. Quality of life in patients

undergoing opioid maintenance therapy – A comparative study of slow release morphine versus methadone treatment. European Psychiatry, 22 (Suppl. 1), 203–204, 2007